Frontiers in Medicine

SJR Rank #5,292H-index: 118SJR: 0.952Best quartile: Q1Open AccessAPC: US$3,801Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Frontiers Media SA

Country

Switzerland

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Medicine (miscellaneous)Q1

Areas: Medicine

Most published research topics

COVID-19 Clinical Research StudiesSepsis Diagnosis and TreatmentRespiratory Support and MechanismsRetinal Diseases and TreatmentsLiver Disease Diagnosis and TreatmentLong-Term Effects of COVID-19Chronic Obstructive Pulmonary Disease (COPD) ResearchSARS-CoV-2 and COVID-19 ResearchIntensive Care Unit Cognitive DisordersGlaucoma and retinal disorders

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs025005000750010000

Documents per Year

2022202501500300045006000

Detailed Information

ISSN

2296-858X

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.36

References per Document

42.87

Coverage

2014-2026

Scope

Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world

Metrics from SCImago Journal Rank 2025. View on SCImago